Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials

Precision medicine for disease modification in Parkinson disease

(2017) Alberto J. Espay et al.   Nature Reviews Neurology

CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study

(2016) Ju-Hee Kang et al.   ACTA NEUROPATHOLOGICA

Presence of cerebral amyloid modulates phenotype and pattern of neurodegeneration in early Parkinson's disease

(2016) Corey T McMillan et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

(2016) Giampaolo Bianchini et al.   Nature Reviews Clinical Oncology

Monitoring of 30 marker candidates in early Parkinson disease as progression markers

(2016) Brit Mollenhauer et al.   NEUROLOGY

How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?

(2016) Tanya Simuni et al.   PARKINSONISM & RELATED DISORDERS

Glucocerebrosidase activity in Parkinson’s disease with and withoutGBAmutations

(2015) Roy N. Alcalay et al.   BRAIN

Disease-Modifying Drugs in Parkinson’s Disease

(2015) Ariane Park et al.   DRUGS

CSF β-Amyloid 1-42 Predicts Progression to Cognitive Impairment in Newly Diagnosed Parkinson Disease

(2015) Mark Terrelonge et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

MDS clinical diagnostic criteria for Parkinson's disease

(2015) Ronald B. Postuma et al.   MOVEMENT DISORDERS

Parkinson risk in idiopathic REM sleep behavior disorder: Preparing for neuroprotective trials

(2015) R. B. Postuma et al.   NEUROLOGY

Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies

(2014) Jose Bras et al.   HUMAN MOLECULAR GENETICS

Ten Years and Counting: Moving Leucine-Rich RepeatKinase 2 Inhibitors to the Clinic

(2014) Andrew B. West   MOVEMENT DISORDERS

The ongoing pursuit of neuroprotective therapies in Parkinson disease

(2014) Dilan Athauda et al.   Nature Reviews Neurology

Predictors of dementia in Parkinson's disease; findings from a 5-year prospective study using the SCOPA-COG

(2014) Kangdi Zhu et al.   PARKINSONISM & RELATED DISORDERS

Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease

(2014) Michael A. Schwarzschild et al.   JAMA Neurology

Parkinson Disease Subtypes

(2014) Mary Ann Thenganatt et al.   JAMA Neurology

How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: Comparison with the unified Parkinson's disease rating scale

(2013) Glenn T. Stebbins et al.   MOVEMENT DISORDERS

Histological, molecular and functional subtypes of breast cancers

(2011) Gautam K. Malhotra et al.   CANCER BIOLOGY & THERAPY

The Parkinson Progression Marker Initiative (PPMI)

(2011) Kenneth Marek et al.   PROGRESS IN NEUROBIOLOGY

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS